| STREAM | RAF | p-value | OR | BETA | CI | Study |
| DOWNSTREAM |
|
0.000004
(EA)
|
|
|
|
22566498
|
|
Turner ST 2012-05-07 Hypertension
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
|
| DOWNSTREAM |
|
0.0000009
(EA)
|
|
1.4
(unit increase)
|
[0.79-2.01] |
22566498
|
|
Turner ST 2012-05-07 Hypertension
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
|
| MAPPED |
|
0.00000003
|
|
|
|
24941225
|
|
Liang Y 2014-06-18 PLoS One
Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.
|
| MAPPED |
|
0.0000000000004
|
|
49.78
(pg/ml increase)
|
[36.41-63.15] |
22367966
|
|
Lin X 2012-02-24 Hum Mol Genet
Genome-wide association study identifies novel loci associated with serum level of vitamin B12 in Chinese men.
|
| MAPPED |
|
0.0000000000000000008
|
|
|
|
24941225
|
|
Liang Y 2014-06-18 PLoS One
Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.
|
| MAPPED |
0.38 |
(CA19-9)
|
|
0.282
(U/ml increase)
|
[0.20-0.37] |
23300138
|
|
He M 2013-01-07 Gut
A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
|
| MAPPED |
0.33 |
0.00000000000000000000000000000000001
(CEA)
|
|
0.073
(ng/ml increase)
|
[0.048-0.098] |
23300138
|
|
He M 2013-01-07 Gut
A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
|
| MAPPED |
0.33 |
(CA19-9)
|
|
0.481
(U/ml decrease)
|
[0.44-0.52] |
23300138
|
|
He M 2013-01-07 Gut
A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
|
| MAPPED |
0.2 |
0.00000000000000000000000000000000000000000000000000000002
(CA19-9)
|
|
0.169
(U/ml decrease)
|
[0.11-0.22] |
23300138
|
|
He M 2013-01-07 Gut
A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
|
| MAPPED |
0.11 |
0.0000000009
(DG12)
|
|
0.3
(unit decrease)
|
[0.20-0.40] |
21203500
|
|
Lauc G 2010-12-23 PLoS Genet
Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.
|
| MAPPED |
0.11 |
0.000000000003
(DG7)
|
|
0.34
(unit decrease)
|
[0.24-0.44] |
21203500
|
|
Lauc G 2010-12-23 PLoS Genet
Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.
|
| MAPPED |
0.11 |
0.000000000001
(FUC-A)
|
|
0.34
(unit decrease)
|
[0.24-0.44] |
21203500
|
|
Lauc G 2010-12-23 PLoS Genet
Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.
|
| MAPPED |
0.11 |
0.00000000000000004
(DG9)
|
|
0.41
(unit decrease)
|
[0.31-0.51] |
21203500
|
|
Lauc G 2010-12-23 PLoS Genet
Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.
|